NLP-Based Feedback for Prostate Cancer

N/A

Recruiting

Led By Timothy Daskivich

Research Sponsored by Cedars-Sinai Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up data will be captured during the treatment consultation, for duration of the study up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new feedback system that uses Natural Language Processing (NLP) in 20 consultations for men diagnosed with prostate cancer. The study will involve patients from the practices of 10

Who is the study for?

This trial is for men who are having their first treatment talk for localized prostate cancer or those on active surveillance with worsening cancer considering local therapy. Participants must be patients at Cedars-Sinai and able to read and write in English.

What is being tested?

The study tests an NLP-based feedback system during consultations with men newly diagnosed with prostate cancer. It aims to improve communication by reporting key consultation points back to patients and doctors within two weeks.

What are the potential side effects?

Since this trial involves a feedback system rather than medication, traditional side effects like you'd see with drugs aren't expected. The focus is on improving understanding of the condition and treatment options.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ data will be captured during the treatment consultation, for duration of the study up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~data will be captured during the treatment consultation, for duration of the study up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and data will be captured during the treatment consultation, for duration of the study up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Decisional Conflict Scale Scores before and after intervention (patient-level outcome)

Change in risk perception before and after intervention (patient-level outcome)

Difference between reported risk of side effects and prognosis with gold standard (physician-level outcome)

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: NLP Intervention Experimental ArmExperimental Treatment1 Intervention

20 men with newly diagnosed clinically localized prostate cancers and utilize NLP to extract key content using the top five sentences by NLP probability for key content areas will be generated and will be provided to patients and providers within 2 weeks after each case.

Do I qualify?Apply below to find out